Clinical Trial Update: Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases [Phase 1]

View source ↗

Summary

Phase 1 trial update on nonmyeloablative allogeneic stem cell transplantation for systemic lupus erythematosus and systemic sclerosis, with the study status lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus
• Systemic Sclerosis

Snippet

Sponsor: Duke University | Conditions: Systemic Lupus Erythematosus, Systemic Sclerosis | Phase 1 | Status: TERMINATED